Nate Hall

[Nate Hall @NathnHall]

@AlderLaneEggs @money4nowand that you loading more Feb 12.5 calls today 🧐

[Nate Hall @NathnHall]

@V_arrell Still holding $3 leaps but the upcoming vote on potential r/s has me nervous. $CRON looking strong

[Max Schwartz @MaximusKannabis]

“Currently there are over 30,000 practitioners treating more than six million patients in 43 U.S. jurisdictions,” DEA said. “Such practices demonstrate that there is no longer a lack of accepted safety for use of marijuana under medical supervision, and as such, marijuana does not fulfill the requirements of being a Schedule I substance.”

https://t.co/M9dX4MMOdd

[Nate Hall @NathnHall]

Wu-Tang Forever

[Brady Watt @Nyceonthebass]

Bass & Bars EP84 ft. Inspectah Deck of Wu-Tang Clan "Triumph, Above The Clouds, C.R.E.A.M."

Today we present to you this epic trilogy featuring one of the illest + most influential lyricists of all time. @INSpectahDECKWU @Ian_Schwartzman @REALDJPREMIER @RZA @WuTangClan

[Nate Hall @NathnHall]

Huge news.. Let’s go! $GLASF 🔜 $GLAS

https://t.co/O5eFe532vu

[Nate Hall @NathnHall]

Curaleaf out here sponsoring anything 😂😂 $CURLD $CURA

[Daily Loud @DailyLoud]

Man smokes weed at the lowest depth underground ever

[Nate Hall @NathnHall]

$GLASF Investor Sesh V
NYSE: $GLAS 👀

[Nate Hall @NathnHall]

@Safebank101 The posts are part of a coordinated (paid) push, much like an ad campaign, but positive for bringing eyes to the Trulieve news and overall sector opportunity. Doubt JPM is buying until after the hearings/ full rescheduling decision, but would love to be wrong.

[Nate Hall @NathnHall]

$TRLV Noticing some large accounts start to post about Trulieve’s uplist to NYSE. Many of the same accounts that previously pushed out the Trump rescheduling rumors 👀⏳ $MSOS

[Nate Hall @NathnHall]

@its_ryan_jensen 3.6M followers…

[Mario Nawfal @MarioNawfal]

🇺🇸 Trulieve ($TRLV) is now trading on the NYSE.

It's the first major U.S. cannabis operator to secure a listing on a premier U.S. exchange: a milestone many thought was still years away.

The cannabis industry just took a major step toward the financial mainstream.

Writer: Val

[Nate Hall @NathnHall]

@its_ryan_jensen 4.3M followers…

[Massimo @Rainmaker1973]

A U.S. cannabis company has joined the New York Stock Exchange for the first time in history. Trulieve, a Florida-based operator, has made history as the first American cannabis business to trade on the NYSE, representing a major milestone in the industry’s acceptance by regulators, investors, and the scientific community.

For decades, marijuana’s classification as a Schedule I substance under federal law created significant obstacles for cannabis companies. Despite the rapid growth of medical and recreational markets across the country, most U.S. cannabis firms were barred from major American stock exchanges and were forced to list on smaller over-the-counter markets or move to Canadian exchanges.

That landscape is now shifting. The listing comes after the federal government rescheduled medical marijuana from Schedule I to Schedule III. Schedule I drugs are defined as having no accepted medical use and high potential for abuse (including substances like heroin and LSD). Schedule III substances, by contrast, have recognized medical applications and face fewer regulatory restrictions.

While this move does not legalize cannabis federally, recreational use remains illegal at the national level, it carries important scientific and financial consequences.

Researchers have long maintained that Schedule I restrictions severely limited rigorous clinical studies on cannabis. Scientists faced heavy bureaucratic hurdles when attempting to study its medical potential, optimal dosing, long-term effects, and interactions with other drugs.

With the new classification, universities and research institutions are expected to pursue more comprehensive clinical trials. This could finally produce stronger, evidence-based data on cannabis’s effectiveness for conditions such as chronic pain, epilepsy, and various neurological disorders.

For investors, Trulieve’s NYSE listing represents a clear signal that cannabis is entering mainstream financial markets. For the scientific community, it opens the door to studies that were previously extremely difficult to conduct.

Regardless of one’s stance on marijuana legalization, it is becoming evident that the future of cannabis will be shaped increasingly by scientific research and empirical data, rather than politics alone.

[Nate Hall @NathnHall]

Sheeesh 🧐

[Fifth Gear @NotFifthGear]

Genesis officially unveils the Magma GT3 and GT concepts!

This car is expected to compete in WEC and Le Mans soon per press release!

[Nate Hall @NathnHall]

@HenryLuMencken @V_arrell $VFF 🤔

[Nate Hall @NathnHall]

@HenryLuMencken @V_arrell @sndl_inc Camped in the leaps as well. Soon enough...

[Nate Hall @NathnHall]

@TheDalesReport @sndl_inc Thought about this when it was happening, but wonder if it was Zach buying those $SNDL shares from $MSOS 🧐

[Nate Hall @NathnHall]

@Bkov9 Best flavor in the game 🥭🔥
(holding a fat stack of $RYM as well)

[Nate Hall @NathnHall]

@ryancavengolf @malbongolf The grateful buckets jacket is clean

[Nate Hall @NathnHall]

@TheDankInformer Recently grabbed a $RYM Señorita at Circle K while visiting Key West. The mango margarita was genuinely delicious and I had a decent sustained buzz from the 10mg

[Nate Hall @NathnHall]

@jonathanrwall Cameron Young's SC Phantom T-9 has all the pros taking notice. Putter on the left is the exact spec with SC graphite shaft into .390 shaft/hosel adapter. Awesome to see BK rocking the copper insert though to match his past Newport bullet back/Teryllium models

[Nate Hall @NathnHall]

@jesseredmond @LeefBrands @aaronvalue I no longer hear or read “SAFE Banking” without Morgan’s yelling sound effects 😅